Inmunoterapia

28 febrero 2011

The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: A Global Allergy and Asthma European Network (GA2LEN) article

Filed under: Del ámbito regulatorio — inmunoterapia @ 13:51

The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: A Global Allergy and Asthma European Network (GA2LEN) article
P. J. Bousquet, M.A. Calderón, P.Demoly, D. Larenas, G. Passalacqua, C. Bachert, J. Brozek, G.W. Canonica, T. Casale, J. Fonseca, R. Dahl, S.R. Durham, H. Merk, M. Worm, U. Wahn, T. Zuberbier, H.J. Schünemann, J. Bousquet.
Journal of Allergy and Clinical Immunology. Volume 127, Issue 1 , Pages 49-56.e11, January 2011

Regulatory aspects of specific immunotherapy in Europe

Filed under: Del ámbito regulatorio — inmunoterapia @ 13:49

Regulatory aspects of specific immunotherapy in Europe
Kaul S; Englert L; May S; Vieths S
Current Opinion in Allergy & Clinical Immunology: December 2010 – Volume 10 – Issue 6 – p 594–602

« Página anterior

Autor: inmunoterapia | Contáctenos
Inmunoterapia con vacunas de alergenos, modalidad terapéutica para las alergias